Lewes, DE -- (SBWIRE) -- 08/14/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Dyax Corp. (NASDAQ:DYAX), Compuware Corporation (NASDAQ:CPWR), Sequenom, Inc. (NASDAQ:SQNM), Peregrine Pharmaceuticals (NASDAQ:PPHM)
Dyax Corp. (NASDAQ:DYAX) opened its shares at the price of $4.32 for the day. Its closing price was $4.07 after gaining +1.50% for the day. The company traded with the total volume of 2.24 million shares, while its average trading volume remained 684,499.00 shares. The beta of DYAX stands at1.63.
Dyax Corp. (Dyax), is a biopharmaceutical company with two business elements: Angioedema Franchise and Phage Display Licensing and Funded Research Program.
Why Should Investors Buy DYAX After The Recent Gain? Just Go Here and Find Out
Compuware Corporation (NASDAQ:CPWR) percentage change surged +0.27% to close at $11.20 with the total traded volume of 2.24 million shares, and average volume of 2.27 million. The 52 week range of the stock remained $7.97 - $12.74, while its day lowest price was $11.06 and it hit its day highest price at $11.38.
Compuware Corporation provides software solutions (both on-premises and Software-as-a-Service (SaaS) models), professional services and application services.
Will CPWR Continue To Move Higher? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) started its trading session with the price of $3.16 and closed at $3.04 by scoring -2.88%. SQNM’s stocks traded with total volume of 2.21 million shares, while the average trading volume remained 4.39 million shares. The beta of SQNM stands at 0.59. Day range of the stock was $3.03 -$3.16.
Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company committed to providing molecular diagnostic testing services, and research use only products.
Has SQNM Found The Bottom and Ready To Move Up? Find Out Here
Peregrine Pharmaceuticals (NASDAQ:PPHM) ended its day with the gain of +1.03% and closed at the price of $1.48 after opening at $1.47. Stock traded during its last trading session with the total volume of 2.21 million shares, as compared to its average volume of 1.39 million shares.
Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer.
For How Long PPHM’s Gloss will Attract Investors? Find out via this report
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/